Claudia Martins

469 total citations
10 papers, 358 citations indexed

About

Claudia Martins is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Claudia Martins has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Ophthalmology and 3 papers in Oncology. Recurrent topics in Claudia Martins's work include Ocular Oncology and Treatments (4 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Claudia Martins is often cited by papers focused on Ocular Oncology and Treatments (4 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Claudia Martins collaborates with scholars based in Canada, Brazil and United States. Claudia Martins's co-authors include Miguel N. Burnier, Sebastian Di Cesare, Bruno F. Fernandes, S. Maloney, Jean‐Claude Marshall, Patrick Logan, E. Antecka, Janet Takefman, Jing Feng and Olga Basso and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Claudia Martins

10 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Martins Canada 8 145 125 97 92 54 10 358
Sandra García‐Mulero Spain 10 127 0.9× 74 0.6× 9 0.1× 110 1.2× 114 2.1× 19 304
Joanne Comerford United States 5 53 0.4× 12 0.1× 57 0.6× 93 1.0× 22 0.4× 5 176
Angela Douglas United Kingdom 8 135 0.9× 226 1.8× 68 0.7× 118 1.3× 55 1.0× 10 483
Nalini Venkatesan India 14 259 1.8× 162 1.3× 9 0.1× 141 1.5× 107 2.0× 25 445
Susan Olalekan United States 7 109 0.8× 4 0.0× 59 0.6× 82 0.9× 179 3.3× 10 344
Berna Beverloo Netherlands 11 237 1.6× 51 0.4× 13 0.1× 95 1.0× 39 0.7× 21 444
Yuker Wang United States 6 204 1.4× 4 0.0× 145 1.5× 171 1.9× 26 0.5× 10 442
Hedda H. van Ravenswaay Claasen Netherlands 7 127 0.9× 3 0.0× 61 0.6× 154 1.7× 180 3.3× 10 401
Pardeep Kaurah Canada 8 182 1.3× 4 0.0× 143 1.5× 130 1.4× 26 0.5× 10 423

Countries citing papers authored by Claudia Martins

Since Specialization
Citations

This map shows the geographic impact of Claudia Martins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Martins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Martins more than expected).

Fields of papers citing papers by Claudia Martins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Martins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Martins. The network helps show where Claudia Martins may publish in the future.

Co-authorship network of co-authors of Claudia Martins

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Martins. A scholar is included among the top collaborators of Claudia Martins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Martins. Claudia Martins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gilbert, Lucy, Timothée Revil, Charles Meunier, et al.. (2017). The empress of subterfuge: cancer of the fallopian tube presenting with malapropism. The Lancet. 390(10098). 1003–1004. 1 indexed citations
2.
Ventura, Bruna V., Carlos Quezada-Ruiz, S. Maloney, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 8. 410–410. 6 indexed citations
3.
Körner, Annett, Adina Coroiu, Claudia Martins, & Béatrice Wang. (2013). Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient’s level of education. International Archives of Medicine. 6(1). 8–8. 30 indexed citations
4.
Gilbert, Lucy, Olga Basso, John S. Sampalis, et al.. (2012). Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. The Lancet Oncology. 13(3). 285–291. 108 indexed citations
5.
Fernandes, Bruno F., Sebastian Di Cesare, Rubens Belfort, et al.. (2011). Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanoma.. SHILAP Revista de lepidopterología. 34(3). 123–30. 10 indexed citations
6.
Fernandes, Bruno F., Sebastian Di Cesare, Rubens Belfort, et al.. (2011). Imatinib Mesylate Alters the Expression of Genes Related to Disease Progression in an Animal Model of Uveal Melanoma. Analytical Cellular Pathology. 34(3). 123–130. 10 indexed citations
7.
Cesare, Sebastian Di, et al.. (2010). Lysyl oxidase expression and inhibition in uveal melanoma. Melanoma Research. 20(2). 97–106. 23 indexed citations
8.
Cesare, Sebastian Di, S. Maloney, Bruno F. Fernandes, et al.. (2009). The effect of blue light exposure in an ocular melanoma animal model. Journal of Experimental & Clinical Cancer Research. 28(1). 48–48. 24 indexed citations
9.
Martins, Claudia, Bruno F. Fernandes, E. Antecka, et al.. (2008). Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye. 22(5). 707–711. 23 indexed citations
10.
Marshall, Jean‐Claude, Patrick Logan, S. Maloney, et al.. (2008). Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma. Clinical Cancer Research. 14(4). 951–956. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026